Streetbeat News

Regulatory

RDHL

RedHill Biopharma's Talicia has been included as a first-line treatment option for Helicobacter Pylori infection in the new American College of Gastroenterology guidelines.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 11:14 am

RNAC

The FDA has granted Rare Pediatric Disease Designation to Cartesian Therapeutics' Descartes-08 for the treatment of Juvenile Dermatomyositis, a rare inflammatory disease. This designation could potentially expedite the development and review process for Descartes-08.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 11:12 am

TNXP

Tonix Pharmaceuticals presented promising data on its potential Mpox vaccine, TNX-801, at an immunology symposium. The vaccine showed efficacy in protecting animals and improved tolerability in immunocompromised subjects. It has been selected by NIH's Project NextGen for clinical testing.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 11:11 am

ACB

Aurora Cannabis Inc. has launched a new CBD lozenge in Canada, developed in collaboration with Vectura Fertin Pharma. The product is available through Aurora's e-commerce platform, marking Vectura's first medical cannabis product in Canada.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 11:08 am

IMVT

ROIV

Immunovant reported positive Phase 2a trial results for Batoclimab in Graves' Disease, showing a 76% response rate in patients uncontrolled on antithyroid drugs. The company plans to start a pivotal trial for IMVT-1402 by the end of 2024, with FDA alignment and IND clearance.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 11:06 am

AKRO

Akero Therapeutics has initiated the Phase 3 Synchrony Outcomes trial by dosing the first patient. This study will assess the efficacy and safety of Efx for treating compensated cirrhosis, fibrosis stage 4, due to metabolic dysfunction-associated steatohepatitis.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 11:03 am

NVDA

Nvidia is under early-stage antitrust investigation by the DOJ and FTC over its dominance in the AI chip market. The investigation is part of a broader scrutiny of tech giants' market practices. Despite a recent stock decline, Nvidia remains a favorite among analysts due to its strong AI sector position.

Portfolio Pulse from Benzinga Neuro

September 09, 2024 | 9:35 am

CTGO

Contango ORE, Inc. has commenced its second campaign of gold ore processing at the Kinross Fort Knox mill in Alaska. The company has also received a key permit for infrastructure development and is advancing its Johnson Tract project with a new economic assessment and ongoing drilling.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 9:05 am

ICE

Intercontinental Exchange, Inc. (ICE) has confirmed the cessation of U.S. dollar LIBOR by September 2024, as announced by the U.K. Financial Conduct Authority. The FCA will not compel ICE Benchmark Administration to continue publishing synthetic U.S. dollar LIBOR settings beyond this date.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 9:03 am

EMCG

Embrace Change has received a warning from Nasdaq due to a delay in filing its quarterly report. The company plans to submit the report by the end of September.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 8:01 am